"We are extremely excited about forming this important collaboration between our companies and scientists that will empower ...

August 07, 2025 - The increasing incidence of cancer and neurological disorders is a major factor driving revenue growth in ...

Revvity, Inc. (NYSE: RVTY), today announced the launch of pHSense™ reagents, a powerful technology designed to advance ...

SkyQuest Technology Consulting published a report, titled, Biomarkers Market - Global Opportunity Analysis and Industry ...

Eko Health, a leader in AI-powered cardiac and pulmonary care, announced the expansion of its Clinical Advisory Board to ...

Q2 2025 Earnings Call Transcript August 4, 2025 Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.15, ...

Senolytic Supplements Market to Reach $350 Million by 2025, Poised for 15% CAGR Through 2032 Driven by growing focus on healthy aging and breakthroughs in cellular senescence-targeted therapies The ...

About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current standard chemotherapy. To better understand why some tumors resist chemoth ...

New approach finds ‘parent-of-origin’ effects in more than a dozen genes — without the need for parental data.

Evelyn Rampler of the Department of Analytical Chemistry at the University of Vienna discusses how her team developed a ...